NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: R
Post# of 87
(Total Views: 746)
Posted On: 08/27/2019 4:10:14 PM
NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Posts Q1 Fiscal 2020 Financial Results, Provides Corporate Update
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning reported financial results for the first quarter ended June 30, 2019. Among other highlights, the company reported an operating income of $2.7 million for the quarter which it primarily attributes to royalty, interest and lease income. Canopy Rivers took advantage of new invest opportunities during the quarter, providing $18.8 million to new investments in Biolumic, Zeakal and High Beauty in addition to contributing a total of $6 million to existing investees Greenhouse Juice Company and Agripharm. “In Q1 2020, we made several exciting investments in plant sciences and cannabis brands, two areas that we think are primed for real growth in the cannabis sector,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “In addition to our new investments, as lifecycle investors, it was also rewarding to see so much positive news coming from our portfolio companies this quarter. From PharmHouse entering into a significant supply agreement with Canopy Growth to TerrAscend becoming, to our knowledge, the first and, so far, only cannabis company with sales in Canada, the U.S., and the European Union, our portfolio companies were busy creating significant value.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning reported financial results for the first quarter ended June 30, 2019. Among other highlights, the company reported an operating income of $2.7 million for the quarter which it primarily attributes to royalty, interest and lease income. Canopy Rivers took advantage of new invest opportunities during the quarter, providing $18.8 million to new investments in Biolumic, Zeakal and High Beauty in addition to contributing a total of $6 million to existing investees Greenhouse Juice Company and Agripharm. “In Q1 2020, we made several exciting investments in plant sciences and cannabis brands, two areas that we think are primed for real growth in the cannabis sector,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “In addition to our new investments, as lifecycle investors, it was also rewarding to see so much positive news coming from our portfolio companies this quarter. From PharmHouse entering into a significant supply agreement with Canopy Growth to TerrAscend becoming, to our knowledge, the first and, so far, only cannabis company with sales in Canada, the U.S., and the European Union, our portfolio companies were busy creating significant value.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)